Company Overview and News

209
A New Generation Of Nontraditional REIT Opportunities

2018-06-22 blog.invesco.us
When most investors think about traditional real estate investment trust (REIT) investment opportunities, they often think about the “four major food groups” of real estate: the retail, office, residential and industrial sectors. While these sectors continue to be a major component of REIT investing, they are increasingly being joined by nontraditional REIT sectors. Our growing reliance on technology and changing demographics are leading to new opportunities in three nontraditional REIT sectors: infrastructure, data centers and timber.
DLR.PRH DLR.PRG FB DLR.PRJ DLR.PRI COR.PRACL AMT.PRB AMT.PRA CONE AMZN AMT RYN COR CCI WY EQIX QTS.PRA PCH COR.PRA DLR QTS SBAC DLR.PRC DLR.PRF IVZ

0
WY / Weyerhaeuser Co. S-3ASR

2018-06-07 sec.gov
Document As filed with the Securities and Exchange Commission on June 7, 2018.
WY

0
WY / Weyerhaeuser Co. / VANGUARD GROUP INC - null (Passive Investment)

2018-05-09 sec.gov
weyerhaeuserco.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
WY

0
WY / Weyerhaeuser Co. / VANGUARD GROUP INC - null (Passive Investment)

2018-05-09 sec.gov
weyerhaeuserco.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
WY

0
0
Money Does Grow On Trees With Weyerhaeuser

2018-04-27 seekingalpha
Management has shown the ability to shave non-core businesses to increase shareholder value and position itself for long-term success.
IP NIJPF INPAP PCL WY

0
WY / Weyerhaeuser Co. 8-K (Current Report)

2018-04-27 sec.gov
Document Table of Contents
WY

0
WY / Weyerhaeuser Co. DEF 14A

2018-04-05 sec.gov
DEF 14A Table of Contents SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
WY

0
WY / Weyerhaeuser Co. DEFA14A

2018-04-05 sec.gov
DEFA14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
WY

6
Louisiana-Pacific Making The Best Of The Cycle

2018-03-14 seekingalpha
Responsible competition and healthy demand has led to a stronger OSB cycle, with very attractive pricing driving good growth and margins for Louisiana-Pacific.
LPX BCC PGEM JHX OSB WWTH WY

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to WY / Weyerhaeuser Co. on message board site Silicon Investor.

Timing the Trade the Wyckoff Way WYNN MACAU
Wynn Resorts The Wyckoff Method
Texas Wyoming Drilling Company Stornoway Diamond Corporation (SWY.V)
(SWY.TO) Executes Mandate Letter With Lead Arrangers for Ren V.FWY (FENRF) - FENWAY RESOURCES
Midway Games - MWY Genesee u0026 Wyoming, Inc. (GWR)
CUSIP: 962166104